Interesting, page-4856

Well, the 'update' today confirms zero progress on enrolment. Just a bunch more excuses why enrolment is so bad. In two months we'll be a year in to a trial looking for a cohort of 15 patients, with zero or one having completed it.

Will IBX waste another year trying to finish this trial? Or have they been proactive in setting up another trial elsewhere while this one falls over?

I don't know what's happening behind the scenes. But over 20k breast cancer diagnosis are made each year. Bob is lamenting the fact that 2500 might have been missed. That leaves a pool of 87.5% remaining for the trial. So CoVid is a factor, but it's a minor factor compared to how the trial has been run (ie a failure).

My 90% is an estimate, I don't think it's more likely to be discontinued than successful, I think it's MUCH more likely to be discontinued than successful.